AUTHOR=Choi Namkee G. , Marti C. Nathan , Choi Bryan Y. TITLE=Changes in and correlates of cannabis-involved substance use treatment admissions age 50 and older, 2000–2021 JOURNAL=Frontiers in Public Health VOLUME=Volume 13 - 2025 YEAR=2025 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1592551 DOI=10.3389/fpubh.2025.1592551 ISSN=2296-2565 ABSTRACT=Background and aimsCannabis use among U.S. older adults has risen rapidly over the past two decades. This study examined the changes in and correlates of cannabis-involved substance use treatment admissions among this demographic.MethodsUsing the 2000–2021 concatenated Treatment Episode Data Set-Admissions (TEDS-A) age 50+ (N=5,593,004), we fitted joinpoint regression models to examine changes in the percent of cannabis-involved admissions of all substance use admissions. We used multinomial and binary logistic regression models to examine the demographic and treatment-related correlates of cannabis-primary admissions and cannabis-secondary/tertiary admissions.ResultsDuring the study period, the number of cannabis-involved admissions increased substantially, while their share of all admissions increased and then decreased as other drug-related admissions increased. The annual percentage changes (APC) show that the shares of cannabis-involved admissions of all admissions between 2000 and 2012 increased for the 50–64 age group and then decreased between 2012 and 2021. In the 65+ age group, the shares increased between 2000 and 2016 (APC=5.2) and then plateaued. Compared to no-cannabis admissions, the likelihood (relative risk ratio) of all cannabis-involved admissions was higher among males, black people, residents of states where medical or recreational cannabis use was legal, and referrals from healthcare providers and court/criminal legal systems. The likelihood (adjusted odds ratio [AOR]) of cannabis-primary admissions was higher among those age 65+ (aOR=1.04, 95%CI=1.00–1.08), black people (aOR=1.34, 95% CI=1.32–1.36), Hispanic people (aOR=1.26, 95% CI=1.23–1.29), residents of states with medical cannabis laws, and those who were referred by healthcare providers and legal systems.ImplicationsCannabis-involved admissions are projected to continue to increase as cannabis use continues to increase. More effective regulations and enforcement of delta-9-tetrahydrocannabinol potency and research on cannabis harms and poly-substance use are needed to protect the health of older adults who turn to cannabis for its purported health benefits. Increased availability and accessibility of treatment infrastructure are also needed.